BioCentury
ARTICLE | Strategy

Rebasing pharma's growth

May 13, 2002 7:00 AM UTC

Blue Shift

If both investors and management of pharma can't wait for 2002 to end, there is one silver lining to this year's likely dismal growth numbers: it will be easier to grow off a smaller base in 2003...